Review decisions
Showing 150 results of 2295 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1697629380576
DIN(s): 02404508, 02420201, 02493586, 02493594, 02494809, 02494817, 02495341, 02495368, 02497026, 02497034, 02502690, 02502704, 02505762, 02505770, 02513781, 02513803, 02515563, 02515571, 02516047, 02516055, 02540746, 02540754
Issued / Original Publication Date: 2023-10-27
Updated Date: 2023-10-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1723138153805
Product Type: Drug
Control Number: 280378
DIN(s): 02527707
Manufacturer: Amylyx Pharmaceuticals Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-10-26
Decision / Authorization Date: 2024-05-02
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1697811489202
Product Type: Drug
Control Number: 268288
DIN(s): 02542250
Manufacturer: Teva Canada Limited
Submission Type: New Drug Submission
Date Filed / Submission Date: 2022-10-04
Decision / Authorization Date: 2023-10-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1699032842238
Product Type: Drug
Control Number: 271331
DIN(s): 02542293, 02542307
Manufacturer: AbbVie Corporation
Submission Type: New Drug Submission (New Active Substance) - Notice of Compliance with Conditions
Date Filed / Submission Date: 2023-01-12
Decision / Authorization Date: 2023-10-13
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1698157968254
Product Type: Drug
Control Number: 272451
DIN(s): 02542315, 02542323, 02542331, 02542358, 02542366
Manufacturer: Sandoz Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-02-27
Decision / Authorization Date: 2023-10-13
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1698845236805
Product Type: Drug
Control Number: 267554
DIN(s): 02495155, 02520893, 02539721
Manufacturer: AbbVie corp.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-11-16
Decision / Authorization Date: 2023-10-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1698782364007
Product Type: Drug
Control Number: 272553
DIN(s): 02469367, 02469375, 02469383, 02469405
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-02-20
Decision / Authorization Date: 2023-09-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1698843751956
Product Type: Drug
Control Number: 266249
DIN(s): 02482592
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-07-20
Decision / Authorization Date: 2023-07-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1715716170652
Product Type: Drug
Control Number: 268982
DIN(s): 02435462, 02435470
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-10-24
Decision / Authorization Date: 2023-10-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1698760127896
Product Type: Drug
Control Number: 259843
DIN(s): 02533464
Manufacturer: Aequus Pharmaceuticals Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-12-20
Decision / Authorization Date: 2022-12-14